Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptides.

European Journal of Pharmacology
P DevillierD Regoli

Abstract

A series of substance P (SP)- and bradykinin (BK)-related peptides have been compared for their histamine-releasing activities on rat peritoneal mast cells. Some of these peptides only differed in the N-acetylation of the N-terminal arginine residue or by the removal of charged residue at the N-terminal. The aim was to examine the role of the N-terminal positive charges in the histamine-releasing activity of compounds that are selective for the SP receptor (named NK-1) or for the B2 type bradykinin receptor. Only compounds with positive charges at the N-terminal caused non-cytotoxic histamine release from rat mast cells. It is suggested that SP- and BK-related peptides caused histamine release by a mechanism which appeared to be non-specific and not related to the activation of mast cell NK-1 or B2 receptors, respectively. Our results show that NK-1 agonists or B2 antagonists devoid of histamine-releasing activity, which could be of potential use in the clinic, can be obtained by removing the positively charged N-terminal aminoacids or by N-acetylation of the N-terminal arginine.

References

Jun 1, 1975·Journal of Immunological Methods·R P Siraganian
Oct 29, 1985·European Journal of Pharmacology·P DevillierD Regoli
Jan 1, 1986·International Archives of Allergy and Applied Immunology·H AliJ C Foreman
Jul 1, 1987·Neuropeptides·G DrapeauD Regoli
Apr 27, 1988·European Journal of Pharmacology·P DevillierD Regoli
Mar 21, 1988·Neuroscience Letters·E Burcher, L A Chahl
Apr 9, 1986·European Journal of Pharmacology·D RegoliJ Barabé
May 1, 1988·Trends in Pharmacological Sciences·A Abbott
Mar 1, 1988·The American Review of Respiratory Disease·D ProudR M Naclerio
Dec 1, 1987·British Journal of Pharmacology·M SchachterJ M Stewart
Mar 1, 1985·Peptides·R J Vavrek, J M Stewart
Apr 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·A R Johnson, E G Erdös
Sep 1, 1971·Journal of Medicinal Chemistry·F W Dunn, J M Stewart
Jul 17, 1981·European Journal of Pharmacology·T C Theoharides, W W Douglas
Sep 1, 1982·The Journal of Physiology·C M FewtrellJ M Stewart
Jan 1, 1983·Peptides·M E Hall, J M Stewart
Feb 1, 1983·Acta Physiologica Scandinavica·R HåkansonJ Hörig
Jan 27, 1984·European Journal of Pharmacology·D RegoliJ Mizrahi
Oct 1, 1984·British Journal of Pharmacology·K FolkersS Leander

❮ Previous
Next ❯

Citations

Nov 1, 1992·Agents and Actions·D M Grassi-Kassisse, G Ribeiro-DaSilva
Jan 1, 2000·Archives of Pharmacal Research·D H KimW B Kim
May 12, 1994·European Journal of Pharmacology·C M GiraldeloE Antunes
Mar 7, 1996·European Journal of Pharmacology·M MorishitaS Torii
Jan 1, 1994·Immunopharmacology·M MousliC Bronner
Jan 1, 1995·Neurochemistry International·K WalkerA Dray
Jan 1, 1995·General Pharmacology·J P Dehaye, V Verhasselt
Aug 16, 1994·European Journal of Pharmacology·J ZhuT D Hexum
Sep 30, 2000·European Journal of Pharmacology·T Andoh, Y Kuraishi
Aug 11, 1998·European Journal of Pharmacology·T GriesbacherF Lembeck
Jun 5, 2003·Toxicon : Official Journal of the International Society on Toxinology·Paula R S CâmaraEdson Antunes
Jun 18, 1997·Regulatory Peptides·C A Maggi
May 5, 1998·Fundamental & Clinical Pharmacology·A ChahdiY Landry
Oct 1, 1995·British Journal of Pharmacology·A AhluwaliaC A Maggi
Jan 1, 1991·Annals of the New York Academy of Sciences·D RegoliP d'Orléans-Juste
Apr 1, 1991·The American Review of Respiratory Disease·W M AbrahamA Cortes
Sep 1, 1991·The American Review of Respiratory Disease·G BraunsteinN Frossard
Apr 1, 1992·The American Review of Respiratory Disease·P H JarreauI Macquin-Mavier
Feb 11, 2012·Critical Reviews in Immunology·Alasdair M Gilfillan, Michael A Beaven
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric GrazziniPaola M C Lembo
Oct 1, 1992·Kidney International·I Gavras
Feb 22, 2011·Peptides·Stanislas Grassin-DelyleHélène Merle-Béral
Jul 29, 2008·Biochemical and Biophysical Research Communications·Hidehito MukaiEisuke Munekata
Apr 20, 2004·Regulatory Peptides·Astrid RydningJon Erik Grønbech
May 5, 2012·European Journal of Pharmacology·Tatsuo SakamotoMio Miyake
Nov 8, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Tine V KarlsenEli-Anne B Gjerde

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.